Financial results - BICON PHARMA SRL

Financial Summary - Bicon Pharma Srl
Unique identification code: 36660199
Registration number: J23/4216/2016
Nace: 4773
Sales - Ron
412.322
Net Profit - Ron
-4.168
Employee
4
The most important financial indicators for the company Bicon Pharma Srl - Unique Identification Number 36660199: sales in 2023 was 412.322 euro, registering a net profit of -4.168 euro and having an average number of 4 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Bicon Pharma Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 0 143.620 283.041 311.692 322.804 358.963 398.054 412.322
Total Income - EUR - - 0 143.621 283.044 311.707 322.807 373.251 398.086 412.324
Total Expenses - EUR - - 3.379 143.389 260.411 296.894 318.009 350.320 395.299 412.575
Gross Profit/Loss - EUR - - -3.379 232 22.634 14.813 4.798 22.931 2.787 -251
Net Profit/Loss - EUR - - -3.379 -1.205 19.799 11.692 1.798 19.469 -601 -4.168
Employees - - 1 4 4 4 4 3 4 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 3.9%, from 398.054 euro in the year 2022, to 412.322 euro in 2023.

Check the financial reports for the company - Bicon Pharma Srl

Rating financiar

Financial Rating -
Bicon Pharma Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Bicon Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Bicon Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Bicon Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Bicon Pharma Srl - CUI 36660199

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 2.629 1.903 1.203 27.295 20.645 15.205 9.379 4.331
Current Assets - - 1.095 36.291 55.497 59.153 55.781 60.237 68.272 67.827
Inventories - - 1.003 26.872 33.544 40.867 41.018 45.200 49.668 43.795
Receivables - - 0 5.765 13.094 9.886 9.780 11.190 12.790 12.242
Cash - - 92 3.654 8.858 8.399 4.983 3.847 5.813 11.790
Shareholders Funds - - -3.335 -4.483 15.398 26.792 22.935 36.362 29.748 23.292
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 7.060 42.677 41.302 59.655 53.491 39.080 47.908 48.866
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 67.827 euro in 2023 which includes Inventories of 43.795 euro, Receivables of 12.242 euro and cash availability of 11.790 euro.
The company's Equity was valued at 23.292 euro, while total Liabilities amounted to 48.866 euro. Equity decreased by -6.366 euro, from 29.748 euro in 2022, to 23.292 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Bicon Pharma Srl

Comments - Bicon Pharma Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.